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Abstracts / Urological Science 26 (2015) S26eS35S32Purpose: To compare the efﬁcacy of prophylactic antibiotics in reduction
of post-operative infections in patients undergoing ureterorenoscopy
(URS) as the intervention.
Materials and Methods: The study is a open-labeled, prospective, ran-
domized controlled trial. Between 2012 to 2015, 45 patients with preop-
erative sterile urine undergoing URS were randomly and eqully allocated
by the randomization to three groups, and each group received prophy-
lactic antibiotics with single-dose intravenous cefazolin (1gm), oral
cefuroxime (500mg) or placebo (control group), respectively. The Urine
analysis and urine cultures were obtained around postoperative day 5 to 7.
We deﬁned pyuria as WBCS 10/HPF at urine sediment study, and signif-
icant bacteriuria was deﬁned as S105 CFU pathogens/ml in the urine.
Febrile urinary tract infection (fUTI) was deﬁned as body temperature
more than 38 Celsius degree with pyuria or signiﬁcant bacteriuria within 7
days post-operatively.
Results: Total 45 patients were recruited for the analysis. The post-
operative pyuriawere signiﬁcantly lower in patients with prophylaxis than
the placebo group (42.2% vs. 70.0%, p ¼ 0.04). Patients receiving prophy-
lactic antibiotics with cefazolin and oral cefuroxime were subjected to
signiﬁcantly lower risks of pyuria compared with the control group (36.0%
and 48.5% vs. 70.%, p < 0.05).
There are the trends that the rates of bacteriuria and fUTI were be lower
in patients underwent prophylaxis, though they were not statistically
signiﬁcant (3.5% vs 9.8%, p ¼ 0.1, 1.1% vs. 4.9%, p ¼ 0.08). There was no
signiﬁcant difference in rates of bacteriuria and fUTI between the three
groups.
Conclusions: Antibiotic prophylaxis signiﬁcantly reduces the incidence of
pyuria following URSL and tends to decreased the risk of bacteriuria and
UTI.
IPD23:
PSYCHOGENIC CAUSE IS NOT THE MAIN RISK FACTOR FOR ERECTILE
DYSFUNCTION IN YOUNG MEN COMPARED TO THE AGING GROUP
Yin-Chien Ou, Yung-Ming Lin. Department of Urology, National Cheng Kung
University Hospital, Tainan, Taiwan
Purpose: The erectile dysfunction (ED) is more prevalent in elderly,
and the common risk factors for patients above the age of 40 have
been well studied. However, there is increasing tendency of men under
the age of 40 seeking for help for ED. Conventionally, psychological
factor is considered to be the likeliest reason in these patients. The aim
of this study is to compare the prevalence of psychogenic cause and
the other risk factors associated with ED between the young and aging
groups.
Materials and Methods: From June 2013 to November 2014, total 331
patients presented to our out-patient clinic with chief complaint of ED
were enrolled. The clinical characteristics, underlying diseases, current
medications, IIEF-5 questionnaire, Hospital Anxiety and Depression Scale
(HADS), biochemical and hormonal proﬁles and penile duplex Doppler
ultrasonography were collected. The patients were divided into young age
group (age 40) and old age group (age >40). Chi-square test and Fisher’s
exact test were used to evaluate the difference in the prevalence of the risk
factors between the two groups.
Results: Of the 331 patients, 60 (18.1%) were in the young age group.
According to the score of IIEF-5, patients in the young age group were
though to have mild to moderate disease (IIEF-5: 12~21), compared to
the patient in the old age group who were more likely to have
moderate to severe disease (IIEF-5: 5~11) (P ¼ 0.015). The anxiety
portion of the HADS showed no difference between two groups;
however, higher prevalence of depression was noted in the old age
group (P ¼ 0.024). In addition, higher prevalence of hypertension as
well as diabetes mellitus was found in the old age group. No differ-
ence in the over-weight or obesity parameter (BMI), dyslipidemia
parameters and the smoking condition were found between the two
groups. The old age group also had a higher frequency on the ﬁndings
of penile duplex Doppler, such as arterial insufﬁciency or veno-
occlusive dysfunction (P < 0.001).
Conclusion: The prevalence of anxiety or depression in the young men
with ED is not higher than those in old age group. Instead, the elderly with
ED tend to have depression problem. Similar prevalence of dyslipidemiaand BMI distribution in the two groups suggest that young men with ED
indeed possess some organic risk factors.
IPD15:
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Purpose: To determine whether there were any changes in the aetiology
and management of urethral strictures in China.
Materials and Methods: The data from 4764 male patients with urethral
stricture disease who underwent treatment at 13 medical centres in China
between 2005 and 2010 were retrospectively collected. The databases
were analysed for the possible causes, site and treatment techniques for
the urethral stricture, as well as for changes in the urethral stricture
aetiology and management.
Results: The most common cause of urethral strictures was trauma, which
occurred in 2466 patients (51.76%). The second most common cause was
iatrogenic injures, which occurred in 1643 patients (34.49%). The most
common techniques to treat urethral strictureswere endourological surgery
(1740, 36.52%), anastomotic urethroplasty (1498, 31.44%) and substitution
urethroplasty (1039, 21.81%). A comparisonbetween theﬁrst threeyears and
the last three years showed that the constituent ratio of endourological
surgery decreased from 54% to 32.75%, whereas the constituent ratios of
anastomotic urethroplasty and substitution urethroplasty increased from
26.73% and 19.18% to 39.93% and 27.32%, respectively (P＜0.05).
Conclusions:During recentyears, therehasbeenan increase in the incidence
of urethral strictures caused by trauma and iatrogenic injury. Endourological
urethral surgery rates decreased signiﬁcantly, and open urethroplasty rates




NOVEL CANCER THERAPEUTICS WITH ALLOSTERIC MODULATION OF
THE MITOCHONDRIAL C-RAF/DAPK COMPLEX BY RAF INHIBITOR
COMBINATION THERAPY
Tai-Lung Cha, Yi-Ta Tsai, Guang-Huan Sun, Sun-Yran Chang, Dah-Shyong
Yu, Cheng-Ping Ma. Division of Urology, Department of Surgery, Tri-Service
General Hospital, National Defense Medical Center, Taiwan
Abstracts / Urological Science 26 (2015) S26eS35 S33Purpose:Mitochondria are the powerhouses of cells. Mitochondrial C-Raf is
a potential cancer therapeutic target, as it regulates mitochondrial function
and is localized to themitochondria by its N-terminal domain. However, Raf
inhibitor monotherapy induced S338 phosphorylation of C-Raf (pC-RafS338)
and impede therapy which is urged to be overcome in clinical practice.
Materials and Methods: We analyzed the growth-inhibition effect of Sor-
afenib and GW5074 combination therapy on multiple normal and cancer
cell lines by MTT assay in vitro and its anticancer effect with xenograft and
orthotopic metastasis animal models in vivo. The molecular mechanisms
involved in the regulation of mitochondrial function have been investigated
by means of western blotting analysis, fractionation, immunoprecipitation
assays and FACS analysis. The protein expression in cancer tissues and
normal counterparts was examined by immunohistochemistry assay.
Results: This study identiﬁed the interaction of C-Raf with S308 phosphor-
ylated DAPK (pDAPKS308), which together became co-localized in the mito-
chondria to facilitate mitochondrial remodelling. Combined use of the Raf
inhibitors sorafenib and GW5074 had synergistic anti-cancer effects in vitro
and in vivo, but targeted mitochondrial function, rather than the canonical
Raf signaling pathway. C-Raf depletion in knock-out MEFC-Raf-/- or siRNA
knock-down ACHN renal cancer cells abrogated the cytotoxicity of combi-
nation therapy. Crystal structure simulation showed that GW5074 bound to
C-Raf and induced a C-Raf conformational change that enhanced sorafenib
binding afﬁnity. In the presence of pDAPKS308, this drug-target interaction
compromised themitochondrial targetingeffect of theN-terminal domain of
C-Raf, which induced two-hit damages to cancer cells. First, combination
therapy facilitated pC-RafS338 and pDAPKS308 translocation from mitochon-
dria to cytoplasm, leading tomitochondrial dysfunction and ROS generation.
Second, ROS facilitated PP2A-mediated de-phosphorylation of pDAPKS308 to
DAPK. PP2A then dissociated from the C-Raf-DAPK complex and induced
profound cancer cell death. Increased pDAPKS308 modiﬁcation was also
observed in renal cancer tissues, which correlated with poor disease-free
survival and poor overall survival in renal cancer patients.
Conclusions: Besides mediating the anti-cancer effect, pDAPKS308 may
serve as a predictive biomarker for Raf inhibitors combination therapy,
suggesting an ideal pre-clinical model that is worthy of clinical translation.
IPD25:
HIGHER EXPRESSION OF ACETYL-TUBULIN MAY INDUCE DOCETAXEL
RESISTANCE IN PROSTATE CANCER CELLS
Yu-Hua Lin 1, Yu-Chuan Lu 2, Chao-Yuan Huang 2, Ying-Fang Su 3, Tzyh-
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Purpose: Docetaxel-based chemotherapy has generally been considered
as one of the effective treatments for prostate cancer. Unfortunately,
clinical treatment with docetaxel often encounters a number of undesir-
able side effects, including drug resistance. Therefore, it has become
essential to identify molecular events that may be associated with the
development of docetaxel resistance. Tubulin isoforms have been previ-
ously examined for their resistant ability to docetaxel in many cancers, but
their real mechanisms remained unclear. In this study, we evaluated the
feasibility of employing docetaxel as a cytotoxic agent for PC3 cells and to
examine the role of acetyl-tubulin in docetaxel-resistant prostate cancer.
MaterialsandMethods:Aseries ofdocetaxel-resistant PC/DXcell subclones,
were established by chronically exposing PC3 to progressively increased
concentrations of docetaxel. Herein, we characterized the docetaxel-medi-
ated cytoxicity and molecular events in PC3 and PC/DX cells by MTT assay,
Western blotting, RT-PCR, real-time PCR and ﬂow cytometry analysis.
Results: Our results showed that levels of acetyl-tubulin, a-tubulin, b-
tubulin, g-tubulin, and bIII-tubulin were signiﬁcantly higher expression in
PC/DX25 than in parental PC3 cells byWestern blotting analysis. PC/DXwith
greater resistance to docetaxel had higher levels of acetyl-tubulin andMCAK
(mitotic centromere associate kinesin) than in PC3 cells. The expression ofacetyl-tubulin and MCAK was gradually increased by docetaxel in a dose-
and time-dependent manner in PC3 cells. Histone deacetylase 6, a deacetyl
enzyme of tubulin, mRNA and protein levels were signiﬁcantly decreased in
PC/DX25 than in PC3 cells. PC3 increased the chemoresistant ability to
docetaxel by HDAC6 knockdown and Tubastain A (HDAC6 inhibitor),
respectively. Conversely, PC/DX25 reversed the sensitivity to docetaxel by
MCAK knockdown. Notably, MCAK knockdown in PC/DX25 induced cell
cycle G2/M phase arrest after docetaxel treatment by ﬂow cytometry anal-
ysis. Overexpression of Plk1 in PC3 increased the cell survival rate and
resistance to docetaxel. Interestingly, we also found an evident up-regula-
tion of acetyl-tubulin protein expression after recombinant epidermal
growth factor treatment in a time-dependent manner in PC3 cells.
Conclusion: Up-regulation of acetyl-tubulin may play an important role in
docetaxel-resistant prostate cancer.
IPD26:
SULF1 OVEREXPRESSION IS A POOR PROGNOSTIC FACTOR IN PATIENTS
WITH UROTHELIAL CARCINOMA
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Purpose: Urothelial carcinoma (UC) originating from bladder (UBUC) and
upper urinary tract (UTUC) is the most common tumor type of urinary
tract. However, its pathogenesis remains obscured. Through data mining
from a published transcriptomic database of UBUCs (GSE31684), we
identiﬁed SULF1 as the most signiﬁcant gene showing upregulation from
early tumor development to progression among those associated with
growth factor activity (GO:0030201). Sulfatase-1 (SULF1), encoded by
SULF1, is an extracellular 6-O-endosulfatase, which selectively removed 6-
O-Sulfate from heparan sulfate proteoglycans (HSPGs), involving in mul-
tiple biologic processes including tumorigenesis and cancer progression
proven in various cancers. However, the signiﬁcance of SULF1 expression
has never been evaluated in UC. We therefore analyze its signiﬁcance in
our well-characterized cohort of UC.
Materials and Methods: Quantigene assay was used to detect SULF1
messenger RNA (mRNA) level in 36 UTUCs and 30 UBUCs. Immunohisto-
chemistry evaluated by H-score was used to determine SULF1 protein
expression in 296 UBUCs and 340 UTUCs. We then correlated protein
expression status with clinicopathological features and evaluated the
prognostic signiﬁcance of SULF1 protein expression for disease-speciﬁc
survival (DSS) and metastasis-free survival (MeFS).
Results: Increments of SULF1 transcript level were associated with higher
pT status in both UTUC and UBUC (all P < 0.05). SULF1 protein over-
expression was signiﬁcantly associated with advanced primary tumor and
nodal statuses, and presence of vascular invasion in both groups of UC.
SULF1 overexpression not only predicted worse DSS and MeFS by univar-
iate analysis, but implied inferior DSS (UTUC, P < 0.001; UBUC, P ¼ 0.011)
and MeFS (UTUC, P < 0.001; UBUC, P ¼ 0.021) in multivariate analysis.
Conclusion: SULF1 overexpression is associated with advanced tumor
status and implicated adverse clinical outcome for both patients of UTUC
and UBUC. Our study unveiled the important role of SULF1 expression in
tumor progression in UC and may serve as a potential prognostic
biomarker and a novel therapeutic target of UC.
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CHEMOKINE CXCL14 (BRAK) EXPRESSION AND POTENTIAL ROLE IN
HUMAN RENAL CELL CARCINOMA
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